Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas

Rumi Higuchi1, Taichiro Goto1, Yosuke Hirotsu2

  • 1Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan.

Insights

This study identifies specific bacteria, Streptococcus australis and Ralstonia pickettii, in mesothelioma tissues. These bacteria may play a role in mesothelioma development and could be targets for prevention.

Area of Science:

  • Microbiology
  • Oncology
  • Pathology

Background:

  • The human microbiome's role in cancer is increasingly recognized, yet its specific involvement in mesothelioma pathogenesis is largely unexplored.
  • Understanding the microbial composition of mesothelioma is crucial for developing novel diagnostic and therapeutic strategies.

Purpose of the Study:

  • To identify and characterize mesothelioma-specific microbial communities within tumor tissues.
  • To investigate the potential role of identified microbiota in the progression of mesothelioma.

Main Methods:

  • Analysis of eight mesothelioma tissue samples using polymerase chain reaction (PCR) amplification and 16S rRNA gene sequencing.
  • Operational taxonomic unit (OTU) analysis to determine microbial taxon composition.
  • Comparison of microbial profiles in tumor tissues versus adjacent normal lung tissues from three patients.

Main Results:

  • Sixty-one unique OTUs, classified into 36 species, were identified across all analyzed samples.
  • Streptococcus australis and Ralstonia pickettii were consistently abundant in both mesothelioma and adjacent lung tissues.
  • These two species were identified as key components of the mesothelioma-associated microbiota.

Conclusions:

  • Streptococcus australis and Ralstonia pickettii represent mesothelioma-specific microbiota.
  • The identified microbiota are potentially involved in mesothelioma tumor progression.
  • These bacteria offer promising targets for future mesothelioma prevention strategies.